Cocrystal Other Current Assets from 2010 to 2025

COCP Stock  USD 1.73  0.01  0.57%   
Cocrystal Pharma Other Current Assets yearly trend continues to be relatively stable with very little volatility. Other Current Assets are likely to grow to about 2.2 M this year. Other Current Assets is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. View All Fundamentals
 
Other Current Assets  
First Reported
2008-03-31
Previous Quarter
440 K
Current Value
1.7 M
Quarterly Volatility
1.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cocrystal Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cocrystal Pharma's main balance sheet or income statement drivers, such as Interest Expense of 1.7 K, Selling General Administrative of 4.1 M or Selling And Marketing Expenses of 8.9 M, as well as many indicators such as Price To Sales Ratio of 383, Dividend Yield of 0.0 or PTB Ratio of 0.69. Cocrystal financial statements analysis is a perfect complement when working with Cocrystal Pharma Valuation or Volatility modules.
  
Check out the analysis of Cocrystal Pharma Correlation against competitors.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Latest Cocrystal Pharma's Other Current Assets Growth Pattern

Below is the plot of the Other Current Assets of Cocrystal Pharma over the last few years. It is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. Cocrystal Pharma's Other Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cocrystal Pharma's overall financial position and show how it may be relating to other accounts over time.
Other Current Assets10 Years Trend
Pretty Stable
   Other Current Assets   
       Timeline  

Cocrystal Other Current Assets Regression Statistics

Arithmetic Mean1,080,639
Geometric Mean342,217
Coefficient Of Variation141.75
Mean Deviation1,123,283
Median449,000
Standard Deviation1,531,814
Sample Variance2.3T
Range5.9M
R-Value0.22
Mean Square Error2.4T
R-Squared0.05
Significance0.41
Slope71,546
Total Sum of Squares35.2T

Cocrystal Other Current Assets History

20252.2 M
20242.1 M
20231.8 M
20222.3 M
2021618 K
2020449 K
2019169 K

About Cocrystal Pharma Financial Statements

Cocrystal Pharma shareholders use historical fundamental indicators, such as Other Current Assets, to determine how well the company is positioned to perform in the future. Although Cocrystal Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Cocrystal Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cocrystal Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Current Assets2.1 M2.2 M

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.